Billing code
G390A — Supervision Of Chemotherapy For Induction Phase Of Acute Leukemia Or Myeloablative Therapy Prior To Bone Marrow Transplantation (maximum Of 1 Per Induction Phase Or Myeloablative Therapy); And/or Supervision Of CAR-T Infusion (maximum Of 1 Per Infusion); And/or Supervision Of Bispecific Antibody Infusion During Initial Dosing (maximum Of 3 Per Initial Dosing Phase)
G390A is an OHIP billing code from the Schedule of Benefits. Supervision Of Chemotherapy For Induction Phase Of Acute Leukemia Or Myeloablative Therapy Prior To Bone Marrow Transplantation (maximum Of 1 Per Induction Phase Or Myeloablative Therapy); And/or Supervision Of CAR-T Infusion (maximum Of 1 Per Infusion); And/or Supervision Of Bispecific Antibody Infusion During Initial Dosing (maximum Of 3 Per Initial Dosing Phase). Fees: provider $262.40, specialist $0.00, assistant $0.00, anaesthetist $0.00, non-anaesthetist $0.00.
| Provider | Specialist | Assistant | Anaesthetist | Non-anaesthetist |
|---|---|---|---|---|
| $262.40 | $0.00 | $0.00 | $0.00 | $0.00 |
- Code
- G390A
- Description
- Supervision Of Chemotherapy For Induction Phase Of Acute Leukemia Or Myeloablative Therapy Prior To Bone Marrow Transplantation (maximum Of 1 Per Induction Phase Or Myeloablative Therapy); And/or Supervision Of CAR-T Infusion (maximum Of 1 Per Infusion); And/or Supervision Of Bispecific Antibody Infusion During Initial Dosing (maximum Of 3 Per Initial Dosing Phase)
- FHO+ basket
- Not in the FHO+ base rate basket (Schedule 2 or 2B).
- Effective date
- Apr 1, 2025
- Termination date
- No end date
APEX checks every paid claim against the Schedule of Benefits and flags codes billed below what the visit qualified for. See how APEX works · Pricing